Global biotech investors are stepping up activity in Singapore, as the city-state leverages its talent base, R&D strengths and EDB-backed incentives to anchor Asia-Pacific life sciences growth.
Evonik today unveiled its Asia Beauty Science & Innovation Center in Shanghai – a vibrant new hub that supercharges R&D and provides faster, hands-on support to cosmetics and personal-care brands …
Singapore is fast becoming the launchpad for companies targeting Southeast Asia – EDB-backed incentives, seamless regional connectivity and a pro-business ecosystem are fueling bold expansion plans